CD7 Nanobody-Based Immuno-Nanotoxin for Targeted Treatment of T-Cell Acute Lymphoblastic Leukemia
Yangyang Dong,
Fengtao You,
Yifan Zhang
et al.
Abstract:T-cell acute lymphoblastic leukemia (T-ALL) has been plagued by high relapse and mortality rates due to the lack of available targeted treatment options in the clinic. Herein, a CD7specific immuno-nanotoxin based on anti-CD7 nanobody-modified polymersome-mertansine nanoconjugates (aCD7-Ps-DM1) was engineered to enable effective and targeted chemotherapy of orthotopic T-ALL in vivo. aCD7-Ps-DM1 with regulable aCD7 density showed no DM1 leakage while rapid DM1 release under reducing conditions. The aCD7-Ps-DM1 i… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.